Cyclophosphamide
Aplastic Anemia
Thomas Jefferson UniversitySmall moleculePhase 3Active
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 60/ 100
- Competitive Position
- 95/ 100
Competitive context
15 Active assets in the Aplastic Anemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Fludarabine Thomas Jefferson University | Phase 2 | BBB |
TACROLIMUS Thomas Jefferson University | Phase 2 | BB |
FILGRASTIM Thomas Jefferson University | Phase 2 | BB |
Monomethyl Fumarate Thomas Jefferson University | Phase 2 | BB |
Anti-Thymoglobulin, Rabbit M.D. Anderson Cancer Center | Phase 3 | BB |
View all 36 →
Same molecule, other indications
Cyclophosphamide is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →